tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tenaya Therapeutics price target lowered to $4 from $6 at Canaccord
PremiumThe FlyTenaya Therapeutics price target lowered to $4 from $6 at Canaccord
29d ago
Promising Initial Data and Safety Profile Justify Buy Rating for Tenaya Therapeutics’ TN-401
Premium
Ratings
Promising Initial Data and Safety Profile Justify Buy Rating for Tenaya Therapeutics’ TN-401
1M ago
Tenaya Therapeutics Announces Public Offering Pricing
Premium
Company Announcements
Tenaya Therapeutics Announces Public Offering Pricing
1M ago
Tenaya Therapeutics 50M share Spot Secondary priced at $1.20
PremiumThe FlyTenaya Therapeutics 50M share Spot Secondary priced at $1.20
1M ago
FDA Lifts Hold on Tenaya’s MyPEAK-1 Trial
Premium
Company Announcements
FDA Lifts Hold on Tenaya’s MyPEAK-1 Trial
1M ago
Tenaya Therapeutics  files to sell common stock, no amount given
Premium
The Fly
Tenaya Therapeutics files to sell common stock, no amount given
1M ago
Tenaya Therapeutics reports Q3 EPS (12c), consensus (15c)
PremiumThe FlyTenaya Therapeutics reports Q3 EPS (12c), consensus (15c)
2M ago
Promising Clinical Developments and Regulatory Optimism Drive Buy Rating for Tenaya Therapeutics
Premium
Ratings
Promising Clinical Developments and Regulatory Optimism Drive Buy Rating for Tenaya Therapeutics
2M ago
Tenaya Therapeutics presents new interim safety, efficacy data on TN-201
Premium
The Fly
Tenaya Therapeutics presents new interim safety, efficacy data on TN-201
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100